ArticleRenal failure2025

Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD.

Fang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.